InvestorsHub Logo
Followers 28
Posts 6019
Boards Moderated 0
Alias Born 10/30/2013

Re: bow-tie post# 25037

Friday, 05/21/2021 11:02:01 AM

Friday, May 21, 2021 11:02:01 AM

Post# of 27661
HER-Vaxx Re-Formulation Shows Dramatic Ten-Fold Increase in ...
www.asx.com.au › asxpdf › 20150420
immunizations), compared with the earlier virosome-based formulation of HER-Vaxx. HER-Vaxx stimulates a polyclonal antibody response to HER-2/neu, the oncogene which is targeted by the currently used monoclonal antibody Herceptin®. Further, on Friday 17th April, the Company filed new patent applications around the new

https://www.asx.com.au/asxpdf/20150420/pdf/42xzdym1slg09p.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News